BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 5661351)

  • 1. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351
    [No Abstract]   [Full Text] [Related]  

  • 2. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352
    [No Abstract]   [Full Text] [Related]  

  • 3. Aryl-2-halogenoalkylamines. XXII. Derivatives of phenoxyacetic acid: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):873-82. PubMed ID: 5661350
    [No Abstract]   [Full Text] [Related]  

  • 4. Some antitumor agents derived from benzaldehyde nitrogen mustards.
    Florvall L
    Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential anticancer agents. 3. Schiff bases from benzaldehyde nitrogen mustards and aminophenylthiazoles.
    Modi JD; Sabnis SS; Deliwala CV
    J Med Chem; 1970 Sep; 13(5):935-41. PubMed ID: 5458385
    [No Abstract]   [Full Text] [Related]  

  • 6. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
    PĆ¼tter J; Maral R; Bierling R; Steinhoff D
    Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546
    [No Abstract]   [Full Text] [Related]  

  • 7. Derivatives of fluorene. XXX. Rearrangement and antitumor activities of some 9-oxofluorene oximes. 6(5H)-Phenanthridinones. I.
    Pan HL; Fletcher TL
    J Med Chem; 1969 Sep; 12(5):822-5. PubMed ID: 5812195
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Vermeulen NM; Ashton WT; Ryan AJ
    J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract]   [Full Text] [Related]  

  • 9. Some organoboron compounds containing a bis(2-chloroethyl)amino group joined to boron.
    Shealy YF; Struck RF
    J Med Chem; 1969 Sep; 12(5):907-11. PubMed ID: 5812211
    [No Abstract]   [Full Text] [Related]  

  • 10. Dibromodulcitol (NSC-104800)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):165-77. PubMed ID: 4989813
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
    Acton EM; Keyanpour-Rad M; Christensen JE; Tong HH; Kwok RP; Goodman L
    Carbohydr Res; 1972 May; 22(2):477-86. PubMed ID: 5047748
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential carcinolytic agents. VII. Substituted bis(2-methanesulfonoxyethyl)anilines.
    Papanastassiou ZB; Bruni RJ; Estes PB; Wodinsky I
    J Med Chem; 1969 Sep; 12(5):825-8. PubMed ID: 5818089
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of new urethans. p-Ethylsulfonyl- and p-dimethylsulfamoylcarbanilic acid esters.
    Sharghi N; Lalezari I; Niloufari G; Ghabgharan F
    J Med Chem; 1970 Nov; 13(6):1248. PubMed ID: 5479885
    [No Abstract]   [Full Text] [Related]  

  • 14. 1,3,2-dioxaphosphorinane 2-oxides. IV. Preparation of some 2-substituted-5-carbomethoxy-5-methyl-1,3,2-dioxaphosphorinane 2-oxides as potential antitumor agents.
    Billman JH; Roehrig GR
    J Pharm Sci; 1970 Jun; 59(6):861-3. PubMed ID: 5423097
    [No Abstract]   [Full Text] [Related]  

  • 15. Methanesulfonates: the relationship of structure to antitumor activity.
    Sandberg JS; Wood HB; Engle RR; Venditti JM; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):137-229. PubMed ID: 4350012
    [No Abstract]   [Full Text] [Related]  

  • 16. Some 6-substituted nicotinamides: synthesis and antineoplastic activities.
    Ross WC
    Biochem Pharmacol; 1967 Apr; 16(4):675-80. PubMed ID: 4226739
    [No Abstract]   [Full Text] [Related]  

  • 17. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential anticancer agents. Nitrogen mustards of aminophenylthiazoles.
    Modi JD; Sabnis SS; Deliwala CV
    J Med Chem; 1971 Sep; 14(9):887-8. PubMed ID: 5140020
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyrimidines. XXII. 2,4-Diamino-6-aryl-amino-5-pyrimidinecarboxaldehydes and related compounds.
    O'Brien DE; Weinstock LT; Cheng CC
    J Med Chem; 1968 Mar; 11(2):387-8. PubMed ID: 5691280
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening study on Taiwan plants for antitumor activities.
    King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
    Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.